Salivary Immunoglobulins and Prevalent Coronary Artery Disease

Journal of Dental Research

Volumn 89, Issue 4, 2010, Pages 389-394

  Janket, S ^a   Meurman, J H ^b   Baird, A E ^c   Qvarnstrom M ^d   Nuutinen, P ^e   Ackerson, L K ^f   Hong, J ^g   Muthukrishnan, P ^a,h   Van Dyke, T E ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF MASSACHUSETTS   (United States)

^g Boston University   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Coronary artery disease; Infection; Inflammation; Mucosal antigenicity; Salivary immunoglobulins

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G; SECRETORY IMMUNOGLOBULIN;

ADULT; ARTICLE; BACTERIAL INFECTION; CASE CONTROL STUDY; CHEMISTRY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; IMMUNOLOGY; INFLAMMATION; MALE; MIDDLE AGED; MOUTH DISEASE; MUCOSAL IMMUNITY; SALIVA; STATISTICAL MODEL;

ADULT; BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INFLAMMATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MOUTH DISEASES; SALIVA;

EID: 77949580963     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034509359884     Document Type: Article

References (31)

1. Beck JD, Eke P., Lin D., Madianos P., Couper D., Moss K., et al. (2005). Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults. Atherosclerosis 183: 342-348.
2. Birnie DH, Vickers LE, Hillis WS, Norrie J., Cobbe SM (2005). Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest pain [see comment]. Heart 91: 1148-1153.
3. Blake GJ, Ridker PM (2001). High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis. Eur Heart J 22: 349-352.
4. DAiuto F., Ready D., Tonetti MS (2004). Periodontal disease and C-reactive protein-associated cardiovascular risk. J Periodontal Res 39: 236-241.
5. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. (2000). Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis [see comment]. BMJ 321: 208-213.
6. Danesh J., Whincup P., Lewington S., Walker M., Lennon L., Thomson A., et al. (2002). Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis [see comment]. Eur Heart J 23: 371-375.
7. Danesh J., Whincup P., Walker M. (2003). Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis [comment]. Eur Heart J 24: 881.
8. Elkind MSV, Tondella ML, Feikin DR, Fields BS, Homma S., Di Tullio MR (2006). Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke [see comment]. Stroke 37: 790-795.
9. Gardner MJ, Altman DG (1986). Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J Clin Res Ed 292: 746-750.
10. George SL (1984). The required size and length of a phase III trial. In: Cancer clinical trials: methods and practice. Buyse ME, Staquet MI, Sylvester RJ, editors. New York, NY: Oxford University Press, pp. 296-301.
11. Huittinen T., Leinonen M., Tenkanen L., Virkkunen H., Manttari M., Palosuo T., et al. (2003). Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation 107: 2566-2570.
12. Janket SJ, Baird AE, Chuang SK, Jones JA (2003). Meta-analysis of periodontal disease and risk of coronary heart disease and stroke [see comment]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 559-569.
13. Janket SJ, Qvarnstrm M., Meurman JH, Baird AE, Nuutinen P., Jones JA (2004). Asymptotic dental score and prevalent coronary heart disease [see comment]. Circulation 109: 1095-1100.
14. Johansson A., Johansson I., Eriksson M., Ahrén AM, Hallmans G., Stegmayr B. (2005). Systemic antibodies to the leukotoxin of the oral pathogen Actinobacillus actinomycetemcomitans correlate negatively with stroke in women. Cerebrovasc Dis 20: 226-232.
15. Karvonen J., PCurrency signivCurrency signnsalo M., KesCurrency signniemi YA, Hrkk S. (2003). Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108: 2107-2112.
16. Kinane DF, Mooney J., MacFarlane TW, McDonald M. (1993). Local and systemic antibody response to putative periodontopathogens in patients with chronic periodontitis: correlation with clinical indices. Oral Microbiol Immunol 8: 65-68.
17. Kleinbaum DG, Kupper LL, Muller KE, editors (1998). Applied regression analysis and other multivariable methods. 3 rd ed. Pacific Grove, CA: Duxbury Press.
18. Lehtonen OP, Grahn EM, Stahlberg TH, Laitinen LA (1984). Amount and avidity of salivary and serum antibodies against Streptococcus mutans in two groups of human subjects with different dental caries susceptibility. Infect Immun 43: 308-313.
19. Liu R., Yamamoto M., Moroi M., Kubota T., Ono T., Funatsu A., et al. (2005). Chlamydia pneumoniae immunoreactivity in coronary artery plaques of patients with acute coronary syndromes and its relation with serology. Am Heart J 150: 681-688.
20. Muhlestein JB, Anderson JL (2003). Infectious serology and atherosclerosis: how burdensome is the risk ? Circulation 107: 220-222.
21. Pussinen PJ, Alfthan G., Rissanen H., Reunanen A., Asikainen S., Knekt P. (2004). Antibodies to periodontal pathogens and stroke risk. Stroke 35: 2020-2023.
22. Pussinen PJ, Nyyssnen K., Alfthan G., Salonen R., Laukkanen JA, Salonen JT (2005). Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol 25: 833-838.
23. Ridker PM, Hennekens CH, Buring JE, Kundsin R., Shih J. (1999 a). Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 131: 573-577.
24. Ridker PM, Kundsin RB, Stampfer MJ, Poulin S., Hennekens CH (1999 b). Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 99: 1161-1164.
25. Roth GA, Moser B., Roth-Walter F., Giacona MB, Harja E., Papapanou PN, et al. (2007). Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis 190: 271-281.
26. Sderling A. (1989). Practical aspects of salivary analyses: proteins. In: Human saliva: clinical chemistry and microbiology. Tenovuo JO, editor. Boca Raton, FL: CRC Press, pp. 9-17.
27. Tonetti MS, DAiuto F., Nibali L., Donald A., Storry C., Parkar M., et al. (2007). Treatment of periodontitis and endothelial function. N Engl J Med 356: 911-920.
28. Vettore MV, Leal M., Leo AT, da Silva AM, Lamarca GA, Sheiham A. (2008). The relationship between periodontitis and preterm low birth-weight. J Dent Res 87: 73-78.
29. Wong BYL, Gnarpe J. (2005). Chlamydia pneumoniae and acute coronary syndrome. N Engl J Med 353: 525-528.
30. Yamamoto T., Kita M., Oseko F., Nakamura T., Imanishi J., Kanamura N. (2006). Cytokine production in human periodontal ligament cells stimulated with Porphyromonas gingivalis. J Periodontal Res 41: 554-559.
31. Zweig MH, Campbell G. (1993). Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993 ; 39: 561-577. [Erratum appears in Clin Chem 1993 Aug; 39 (8). 1589.]